Skip to main content
. 2021 Aug 3;22(15):8340. doi: 10.3390/ijms22158340

Figure 1.

Figure 1

CCL19, CCL21, and Tailless-CCL21 (Tailless) induce differential signaling through their common receptor CCR7. Overall, CCL19 is a strong agonist of both G-protein signaling, β-arrestin recruitment, and chemotaxis, whereas CCL21 is a weak agonist. Upon cleavage by DC-released proteases, CCL21 is turned into Tailless-CCL21, which resembles CCL19 and, thus, is a strong agonist.